Valuing Trial Designs from a Pharmaceutical Perspective Using Value‐Based Pricing

E-ISSN： 1099-1050|24|11|1468-1482

ISSN： 1057-9230

Source： HEALTH ECONOMICS, Vol.24, Iss.11, 2015-11, pp. : 1468-1482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valuing Trial Designs from a Pharmaceutical Perspective Using Value‐Based Pricing

HEALTH ECONOMICS, Vol. 1057-9230, Iss. 11, 2015-11 ,pp. : 1468-1482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Marginal value-based pricing of additional spectrum assigned to cellular telephony operators

By Sweet R. Viehoff I. Linardatos D. Kalouptsidis N.

Information Economics and Policy, Vol. 14, Iss. 3, 2002-09 ,pp. : 371-384

Elsevier

Access to resources Recommend Favorite

Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context

HEALTH ECONOMICS, Vol. 24, Iss. 3, 2015-03 ,pp. : 294-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valuing Real Options for Network Investment Decisions and Cost-Based Access Pricing

By Franklin Sergio Luis Diallo Madiagne

The Engineering Economist, Vol. 57, Iss. 4, 2012-12 ,pp. : 223-246

Taylor & Francis Ltd

Access to resources Recommend Favorite

Towards Value‐Based Health Care in Medicare

THE AUSTRALIAN ECONOMIC REVIEW, Vol. 48, Iss. 3, 2015-09 ,pp. : 305-313

John Wiley & Sons Inc

Access to resources Recommend Favorite